CommunitiesHR+ HER2-What Are CDK 4/6 Inhibitors?

What Are CDK 4/6 Inhibitors?

SG

Community Member

3 years ago

Questions about CDK 4/6 inhibitors? You are not alone! Read this post and then let us know what questions you have about this treatment. Suzanne - Outcomes4Me Community Host http://bit.ly/3ohzDu4

9
5 comments
Comment
accepted answer

Accepted Answer

CDK 4/6 inhibitors are an important treatment option for HR+ HER2- breast cancer, and it's completely natural to have questions about how they work and what to expect. This resource looks like a great starting point for understanding these medications - feel free to share any specific questions that come up after reading through it, as the community here has valuable experience and insights to offer.

3+ patients found this helpful

VG

Community Member

6 months ago

Does Verzenio treat pik3ca mutations?

JH

Community Member

6 months ago

I start Kisquali after radiation and may combine it with Anaztrozol 1mg. Any thoughts?

JB

Community Member

6 months ago

Jeanne H I've been on Anastrazole for about 2 1/2 years now after having bilateral mastectomy and was on Ibrance 125 mg and then lowered dosage to 100 mg due to side effects. I did not have any radiation. My Oncologist recently switched me to Kisqali 600mg and then lowered dosage to 400 mg. So I'm on my 3rd treatment of Kisqali now. I did experience fatigue, headaches, nausea and lots of hair thinning but since my dosage was change it's not as bad now. I wish you the best with your treatments.

JK

Community Member

6 months ago

I can't open site?🤷🏻

CA

Community Member

2 months ago

CDK 4/6 inhibitors are an important treatment option for HR+ HER2- breast cancer, and it's completely natural to have questions about how they work and what to expect. This resource looks like a great starting point for understanding these medications - feel free to share any specific questions that come up after reading through it, as the community here has valuable experience and insights to offer.

Outcomes4Me

© 2025 Outcomes4Me Inc. All rights reserved.